Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

SPDR Series Trust SPDR S&P Biotech ETF (NY: XBI )

88.25 -0.44 (-0.50%)
Official Closing Price Updated: 8:00 PM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,271,505
Open 88.94
Bid (Size) 88.43 (8)
Ask (Size) 88.49 (1)
Prev. Close 88.69
Today's Range 87.84 - 89.83
52wk Range 81.14 - 105.47
Shares Outstanding 658,250
Dividend Yield 0.03%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Arcutis Biotherapeutics Sees 400% Spike In Retail Buzz As Q4 Beat Fuels After-Hours Rally
Sales of Zoryve, Arcutis' leading dermatology drug, surged 413% year-over-year to $69.4 million, a 55% increase from the previous quarter. 
Via Stocktwits
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH. 
Via Benzinga

Performance

YTD
-3.58%
-3.58%
1 Month
-4.71%
-4.71%
3 Month
-11.75%
-11.75%
6 Month
-12.22%
-12.22%
1 Year
-14.23%
-14.23%

More News

Read More
Ardelyx Stock Rises After-Hours On Q4 Beat, Drug Sales Outlook: Retail Gets Big Dose Of Optimism
Via Stocktwits
SpringWorks Therapeutics Gains Retail Interest Ahead Of Q4 Earnings – What Investors Expect
Via Stocktwits
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
Via Benzinga
Topics ETFs Government World Trade
Exposures Political Tariff
Biotech Stocks Had A Good Week Despite Crosscurrents
Via Talk Markets
Topics ETFs Stocks / Equities
Travere Therapeutics Sparks Retail Frenzy As Stock Hits Over 2-Year High On FDA Approval Plan For Kidney-Disease Drug
Via Stocktwits
Exposures Product Safety
Healthcare And Biotech Playbook As Disruption Gathers Force
Via Talk Markets
Topics ETFs Stocks / Equities
Springworks Stock Soars To Nearly 3-Year High On Buyout Buzz, Retail Sentiment Rockets
Via Stocktwits
Viking Therapeutics Stock Down Over 20% In 2025: Retail Traders Predict Where It Could End The Year
Via Stocktwits
Small- To Mid-Cap Biotech Trades Poised For Gains
Via Talk Markets
Topics ETFs Stocks / Equities
Biogen Rises On FDA Nod for Alzheimer's Drug Dosing Regimen, But Sage Deal Fallout Irks Retail
Via Stocktwits
Exposures Product Safety
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens
Via Stocktwits
Akero Stock Hits Over 18-Month High On MASH Trial Data: Citi Lauds ‘Best-Case Scenario,’ Retail Exuberant
Via Stocktwits
Moderna Retains Retail Support With European COVID-19 Vaccine Tender Win, Stock Hits 2-Week High
Via Stocktwits
Exposures COVID-19
Healthcare And Biotech Stocks Lag The Market Again
Via Talk Markets
Topics Stocks / Equities
'Buy Long Duration Bonds,' Says Bank Of America Strategist: 4 ETFs To Watch As Trump's Deficit Fight Unfolds
Via Benzinga
Topics Bonds ETFs Government
Exposures Debt Markets Political
We Asked Retail How Viking Therapeutics Can Restore Investor Confidence: Majority Say Pursue Buyout Talks
Via Stocktwits
Keros Therapeutics Stock Heads For Record Low After Dosing Halt In Pulmonary Disease Trial, Retail Buzz Spikes
Via Stocktwits
I’m Not Worried About This Pullback
Via Talk Markets
Topics Cryptocurrencies Stocks / Equities
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Via Benzinga
Topics ETFs
Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks
Via Talk Markets
Topics ETFs Stocks / Equities
No Value In Value? Stock Market (And Sentiment Results)
Via Talk Markets
Topics Stocks / Equities
Healthcare And Biotech Stocks Continue Their Slide
Via Talk Markets
Topics ETFs Stocks / Equities
Are You Ready To Trade Biotech Stocks At The Cusp Of A Bear Market?
Via Talk Markets
Topics ETFs Stocks / Equities
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.